• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Spain Brucellosis Market

    ID: MRFR/LS/51837-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    Spain Brucellosis Market Research Report By species (Brucella suis, B. abortus, B. melitensis)-Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Spain Brucellosis Market Infographic
    Purchase Options

    Spain Brucellosis Market Summary

    The Spain Brucellosis market is poised for substantial growth, with a projected increase from 4.65 USD Million in 2024 to 12.5 USD Million by 2035.

    Key Market Trends & Highlights

    Spain Brucellosis Key Trends and Highlights

    • The market is expected to grow at a compound annual growth rate of 9.41 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 12.5 USD Million, indicating robust expansion.
    • In 2024, the market is valued at 4.65 USD Million, reflecting the current investment in brucellosis management.
    • Growing adoption of advanced diagnostic technologies due to increasing awareness of brucellosis is a major market driver.

    Market Size & Forecast

    2024 Market Size 4.65 (USD Million)
    2035 Market Size 12.5 (USD Million)
    CAGR (2025-2035) 9.41%

    Major Players

    Elanco, Fornetti, Intervet, Hipra, Neogen, Biomapas, Vetoquinol, IDT Biologika, Merck Animal Health, Boehringer Ingelheim, CEVA Santé Animale, Virbac, Oxford Immunotec, Pfeiffer, Zoetis

    Spain Brucellosis Market Trends

    Growing awareness of and attempts to improve animal health and food safety are driving significant trends in the brucellosis market in Spain. Better diagnosis and immunization techniques have resulted from the Spanish government's stringent laws and surveillance efforts to combat brucellosis, especially in animals.

    The need for vaccinations and testing services to maintain herd health is growing as farmers and livestock producers become more aware of disease control. The development of vaccines and improvements in diagnostic technology are the main areas of opportunity in the Spanish brucellosis market.

    Using rapid testing kits helps speed up results and stop the disease from spreading, which is important for public health and the farm industry. Furthermore, there is an opportunity to simplify disease monitoring and management through the integration of digital health solutions and veterinary services, which will assist farmers in more efficiently maintaining healthier cattle.

    Recent trends show that the public and private sectors are increasingly working together to improve Brucellosis research and development projects. This involves collaborations between educational institutions and farming associations to provide creative answers to the particular problems facing the Spanish cattle sector.

    A comprehensive approach to disease control is also being promoted by the growing number of educational initiatives that target producers and consumers regarding the significance of vaccination and biosecurity measures. These coordinated actions demonstrate a dedication to maintaining animal health and market stability in Spain and represent a proactive response to the Brucellosis danger.

     

     

    Market Segment Insights

    Spain Brucellosis Market Segment Insights

    Spain Brucellosis Market Segment Insights

    Brucellosis Market species Insights

    Brucellosis Market species Insights

    The Spain Brucellosis Market is primarily segmented into various species, with Brucella suis, B. abortus, and B. melitensis being the key representatives. Brucella suis mainly affects swine and poses a considerable risk to livestock health within Spain, influencing both the agricultural economy and food safety protocols.

    The significance of this species extends beyond livestock, as it can be transmitted to humans, highlighting the need for effective control measures. B. abortus primarily impacts cattle and is associated with reproductive issues, making it a vital concern for the beef and dairy industry in Spain.

    Get more detailed insights about Spain Brucellosis Market

    Key Players and Competitive Insights

    The Spain Brucellosis Market is characterized by a competitive landscape influenced by various factors, including the prevalence of this zoonotic disease in livestock, regulatory frameworks governing animal health, and the increasing emphasis on food safety and public health.

    The market features a blend of local and international players that strive to provide effective solutions in the form of vaccines, diagnostics, and treatment options. In recent years, the market has witnessed a push towards innovation, with companies seeking to enhance their offerings through research and development initiatives.

    Moreover, collaborations and strategic partnerships among industry stakeholders are becoming crucial in driving market growth and expansion. The competitive dynamics are further shaped by the demand for effective disease management in agriculture and livestock sectors, highlighting the importance of tailoring products and services to meet specific regional needs.

    Elanco stands out in the Spain Brucellosis Market due to its robust portfolio of veterinary pharmaceuticals and vaccines. The company's strengths lie in its commitment to research and development, allowing it to offer reliable solutions that address the challenges posed by brucellosis.

    Elanco has established a significant market presence in Spain, recognized for its scientific expertise and customer-centric approach. Its products are designed to ensure animal health and well-being, thereby enhancing productivity in livestock sectors.

    Additionally, Elanco’s strategic relationships with local veterinarians and livestock producers enable it to effectively meet customer needs, making it a trusted partner in managing brucellosis and other related diseases.

    Fornetti has also made a noteworthy impact on the Spain Brucellosis Market, primarily through its dedication to providing high-quality animal health solutions. The company emphasizes innovative product development and has successfully introduced several key products focused on the prevention and management of brucellosis.

    Fornetti's strengths include a solid distribution network and effective marketing strategies that resonate well with local farmers and veterinarians. The company has identified key opportunities for collaboration and partnerships, allowing it to expand its market footprint in Spain.

    Furthermore, Fornetti is known for its proactive approach towards mergers and acquisitions, which bolsters its capacity for rapid growth and adaptability in the competitive landscape. This ongoing commitment to innovation and collaboration positions Fornetti favorably within the Spanish market for brucellosis solutions.

    Key Companies in the Spain Brucellosis Market market include

    Industry Developments

    Recent developments in the Spain Brucellosis Market highlight significant advancements in control measures against the disease affecting livestock. The Spanish government has been actively promoting vaccination programs, which have seen increased involvement from companies like Elanco and Intervet, focusing on innovative vaccine solutions tailored to local breeds.

    In September 2023, it was reported that Hipra launched a new diagnostic tool aimed at early detection of brucellosis in cattle, improving overall herd management.

    Furthermore, Merck Animal Health has reported a continuous investment in Research and Development to enhance their product offerings in this market, while Vetoquinol has collaborated with local veterinary services to strengthen the health infrastructure against brucellosis outbreaks.

    The market has also seen M&A activity, with Zoetis acquiring a local biotech firm specializing in veterinary vaccines in August 2023, signaling a trend towards consolidation among major players such as Boehringer Ingelheim and CEVA Santé Animale.

    Overall, these developments demonstrate the increasing focus on eradicating brucellosis and improving animal health metrics across Spain, reflecting the livestock sector's critical importance to the nation’s economy and food security.

    Future Outlook

    Spain Brucellosis Market Future Outlook

    Market Segmentation

    Brucellosis Market species Outlook

    • Brucella suis
    • B. abortus
    • B. melitensis

    Report Scope

    Report Attribute/Metric Source:Details
    MARKET SIZE 20234.27(USD Million)
    MARKET SIZE 20244.65(USD Million)
    MARKET SIZE 203512.5(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR)9.406% (2025 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    MARKET FORECAST PERIOD2025 - 2035
    HISTORICAL DATA2019 - 2024
    MARKET FORECAST UNITSUSD Million
    KEY COMPANIES PROFILEDElanco, Fornetti, Intervet, Hipra, Neogen, Biomapas, Vetoquinol, IDT Biologika, Merck Animal Health, Boehringer Ingelheim, CEVA Santé Animale, Virbac, Oxford Immunotec, Pfeiffer, Zoetis
    SEGMENTS COVEREDspecies
    KEY MARKET OPPORTUNITIESIncreased government funding initiatives, Growing veterinary diagnostic services, Rising public awareness campaigns, Development of effective vaccines, Strengthening livestock disease management systems
    KEY MARKET DYNAMICSrising incidence of brucellosis, increased livestock exports, government vaccination programs, advances in diagnostic techniques, awareness and educational initiatives
    COUNTRIES COVEREDSpain

    Leave a Comment

    FAQs

    What is the expected market size of the Spain Brucellosis Market in 2024?

    In 2024, the Spain Brucellosis Market is expected to be valued at 4.65 USD Million.

    What will the market value be by 2035?

    By 2035, the Spain Brucellosis Market is projected to reach 12.5 USD Million.

    What is the expected compound annual growth rate (CAGR) for the Spain Brucellosis Market from 2025 to 2035?

    The expected CAGR for the Spain Brucellosis Market from 2025 to 2035 is 9.406%.

    Which species segments are prominent in the Spain Brucellosis Market?

    The prominent species segments in the Spain Brucellosis Market include Brucella suis, B. abortus, and B. melitensis.

    How is the market value distributed among different species in 2024?

    In 2024, Brucella suis is valued at 1.0 USD Million, B. abortus at 2.0 USD Million, and B. melitensis at 1.65 USD Million.

    What will be the value of Brucella suis by 2035?

    By 2035, the value of Brucella suis in the Spain Brucellosis Market is expected to rise to 3.0 USD Million.

    What is the projected market value for B. abortus in 2035?

    The projected market value for B. abortus in 2035 is estimated to be 5.0 USD Million.

    Which companies are the key players in the Spain Brucellosis Market?

    Key players in the Spain Brucellosis Market include Elanco, Intervet, Hipra, and Merck Animal Health among others.

    How will the market for B. melitensis change by 2035?

    The market for B. melitensis is expected to grow to 4.5 USD Million by 2035.

    What are the growth drivers for the Spain Brucellosis Market?

    Growth drivers for the Spain Brucellosis Market include increasing awareness of animal health and advancements in veterinary medicine.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials